- Home
- ELSE vs NRXP Comparison
ELSE vs NRXP Comparison
Compare ELSE & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELSE
- NRXP
- Stock Information
- Founded
- ELSE 1968
- NRXP 2015
- Country
- ELSE United States
- NRXP United States
- Employees
- ELSE N/A
- NRXP N/A
- Industry
- ELSE Industrial Machinery/Components
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- ELSE Industrials
- NRXP Health Care
- Exchange
- ELSE Nasdaq
- NRXP Nasdaq
- Market Cap
- ELSE 14.2M
- NRXP 14.8M
- IPO Year
- ELSE N/A
- NRXP N/A
- Fundamental
- Price
- ELSE $4.23
- NRXP $1.26
- Analyst Decision
- ELSE
- NRXP Strong Buy
- Analyst Count
- ELSE 0
- NRXP 3
- Target Price
- ELSE N/A
- NRXP $31.33
- AVG Volume (30 Days)
- ELSE 3.4K
- NRXP 161.6K
- Earning Date
- ELSE 11-13-2024
- NRXP 11-14-2024
- Dividend Yield
- ELSE N/A
- NRXP N/A
- EPS Growth
- ELSE 26.54
- NRXP N/A
- EPS
- ELSE 0.13
- NRXP N/A
- Revenue
- ELSE $9,289,000.00
- NRXP N/A
- Revenue This Year
- ELSE N/A
- NRXP N/A
- Revenue Next Year
- ELSE N/A
- NRXP N/A
- P/E Ratio
- ELSE $33.07
- NRXP N/A
- Revenue Growth
- ELSE 11.21
- NRXP N/A
- 52 Week Low
- ELSE $3.68
- NRXP $1.10
- 52 Week High
- ELSE $4.40
- NRXP $7.33
- Technical
- Relative Strength Index (RSI)
- ELSE 59.76
- NRXP 46.49
- Support Level
- ELSE $4.03
- NRXP $1.19
- Resistance Level
- ELSE $4.31
- NRXP $1.36
- Average True Range (ATR)
- ELSE 0.09
- NRXP 0.09
- MACD
- ELSE 0.02
- NRXP 0.01
- Stochastic Oscillator
- ELSE 63.54
- NRXP 58.33
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.